Biotech

All Articles

Bivictrix chooses going personal only way to take ADC in to clinic

.Antibody-drug conjugates (ADCs) have actually been at the center of many a billion-dollar biobuck l...

TPG bests up funds to $580M for financial investments throughout life scientific researches

.Property manager TPG, which has sustained biotechs including Sionna Rehabs and also Santa Ana Biogr...

Merck ceases phase 3 TIGIT test in bronchi cancer cells for futility

.Merck &amp Co.'s TIGIT course has suffered an additional obstacle. Months after shuttering a stage ...

After a difficult year, Exscientia folds right into Recursion

.After a year defined through pipe cuts, the variation of its own CEO as well as cutbacks, Exscienti...

Cullinan, after $25M deal, return bispecific to Harbour

.Cullinan Therapy was actually impressed sufficient along with Port BioMed's bispecific immune react...

A closer examine Tough Biotech's Tough 15

.In this full week's episode of "The Best Line," our team're diving into Intense Biotech's yearly St...

Lilly deals with phase 2 failure of tau-targeting med

.The confetti is still flying from Eli Lilly's celebration celebrating the approval of Alzheimer's a...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of significant management hirings, shootings...

Lykos will certainly talk to FDA to reassess its selection complying with rejection of MDMA treatment for trauma

.Complying with an inadequate showing for Lykos Rehabs' MDMA prospect for trauma at a latest FDA adv...

AN 2 halves census, stops stage 3 trial after records let down

.AN2 Therapies is actually rethinking its service in action to lackluster midphase records, pledging...